Dr. Thomas L. Bauer
Claim this profileRiverview Medical Center/Booker Cancer Center
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
16 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage I
Stage II
Stage III
2Lung Cancer
Stage I
Stage II
Stage III
Affiliated Hospitals
Clinical Trials Thomas L. Bauer is currently running
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
More about Thomas L. Bauer
Clinical Trial Related10 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Thomas L. Bauer has experience with
- Tamsulosin
- Biospecimen Collection
- Crizotinib
- Carboplatin
- Paclitaxel
- Nivolumab
Breakdown of trials Thomas L. Bauer has run
Non-Small Cell Lung Cancer
Lung Cancer
Urinary Retention
Anaplastic Large Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas L. Bauer specialize in?
Thomas L. Bauer focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage I patients, or patients who are Stage II.
Is Thomas L. Bauer currently recruiting for clinical trials?
Yes, Thomas L. Bauer is currently recruiting for 4 clinical trials in Red Bank New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Thomas L. Bauer has studied deeply?
Yes, Thomas L. Bauer has studied treatments such as Tamsulosin, Biospecimen Collection, Crizotinib.
What is the best way to schedule an appointment with Thomas L. Bauer?
Apply for one of the trials that Thomas L. Bauer is conducting.
What is the office address of Thomas L. Bauer?
The office of Thomas L. Bauer is located at: Riverview Medical Center/Booker Cancer Center, Red Bank, New Jersey 07701 United States. This is the address for their practice at the Riverview Medical Center/Booker Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.